560 related articles for article (PubMed ID: 12955147)
1. Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha.
Fu J; Gaetani S; Oveisi F; Lo Verme J; Serrano A; Rodríguez De Fonseca F; Rosengarth A; Luecke H; Di Giacomo B; Tarzia G; Piomelli D
Nature; 2003 Sep; 425(6953):90-3. PubMed ID: 12955147
[TBL] [Abstract][Full Text] [Related]
2. Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats.
Fu J; Oveisi F; Gaetani S; Lin E; Piomelli D
Neuropharmacology; 2005 Jun; 48(8):1147-53. PubMed ID: 15910890
[TBL] [Abstract][Full Text] [Related]
3. Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha).
Guzmán M; Lo Verme J; Fu J; Oveisi F; Blázquez C; Piomelli D
J Biol Chem; 2004 Jul; 279(27):27849-54. PubMed ID: 15123613
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
Peters JM; Zhou YC; Ram PA; Lee SS; Gonzalez FJ; Waxman DJ
Mol Pharmacol; 1996 Jul; 50(1):67-74. PubMed ID: 8700121
[TBL] [Abstract][Full Text] [Related]
5. An anorexic lipid mediator regulated by feeding.
Rodríguez de Fonseca F; Navarro M; Gómez R; Escuredo L; Nava F; Fu J; Murillo-Rodríguez E; Giuffrida A; LoVerme J; Gaetani S; Kathuria S; Gall C; Piomelli D
Nature; 2001 Nov; 414(6860):209-12. PubMed ID: 11700558
[TBL] [Abstract][Full Text] [Related]
6. Role of endocannabinoids and their analogues in obesity and eating disorders.
Gaetani S; Kaye WH; Cuomo V; Piomelli D
Eat Weight Disord; 2008 Sep; 13(3):e42-8. PubMed ID: 19011363
[TBL] [Abstract][Full Text] [Related]
7. PPAR alpha mediates peroxisome proliferator-induced transcriptional repression of nonperoxisomal gene expression in mouse.
Motojima K; Peters JM; Gonzalez FJ
Biochem Biophys Res Commun; 1997 Jan; 230(1):155-8. PubMed ID: 9020034
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor alpha induces NADPH oxidase activity in macrophages, leading to the generation of LDL with PPAR-alpha activation properties.
Teissier E; Nohara A; Chinetti G; Paumelle R; Cariou B; Fruchart JC; Brandes RP; Shah A; Staels B
Circ Res; 2004 Dec; 95(12):1174-82. PubMed ID: 15539630
[TBL] [Abstract][Full Text] [Related]
9. PPAR alpha ligand protects during cisplatin-induced acute renal failure by preventing inhibition of renal FAO and PDC activity.
Li S; Wu P; Yarlagadda P; Vadjunec NM; Proia AD; Harris RA; Portilla D
Am J Physiol Renal Physiol; 2004 Mar; 286(3):F572-80. PubMed ID: 14612380
[TBL] [Abstract][Full Text] [Related]
10. The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide.
Lo Verme J; Fu J; Astarita G; La Rana G; Russo R; Calignano A; Piomelli D
Mol Pharmacol; 2005 Jan; 67(1):15-9. PubMed ID: 15465922
[TBL] [Abstract][Full Text] [Related]
11. Role of peroxisome proliferator-activated receptor-alpha in the mechanism underlying changes in renal pyruvate dehydrogenase kinase isoform 4 protein expression in starvation and after refeeding.
Sugden MC; Bulmer K; Gibbons GF; Holness MJ
Arch Biochem Biophys; 2001 Nov; 395(2):246-52. PubMed ID: 11697863
[TBL] [Abstract][Full Text] [Related]
12. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
[TBL] [Abstract][Full Text] [Related]
13. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor-alpha regulates postischemic liver injury.
Okaya T; Lentsch AB
Am J Physiol Gastrointest Liver Physiol; 2004 Apr; 286(4):G606-12. PubMed ID: 14615282
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of hydrolysis-resistant analogs of oleoylethanolamide with potent anorexiant properties.
Astarita G; Di Giacomo B; Gaetani S; Oveisi F; Compton TR; Rivara S; Tarzia G; Mor M; Piomelli D
J Pharmacol Exp Ther; 2006 Aug; 318(2):563-70. PubMed ID: 16702440
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: correlation with induction of heme oxygenase 1.
Colville-Nash PR; Qureshi SS; Willis D; Willoughby DA
J Immunol; 1998 Jul; 161(2):978-84. PubMed ID: 9670978
[TBL] [Abstract][Full Text] [Related]
17. The lipid messenger OEA links dietary fat intake to satiety.
Schwartz GJ; Fu J; Astarita G; Li X; Gaetani S; Campolongo P; Cuomo V; Piomelli D
Cell Metab; 2008 Oct; 8(4):281-288. PubMed ID: 18840358
[TBL] [Abstract][Full Text] [Related]
18. Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain.
Suardíaz M; Estivill-Torrús G; Goicoechea C; Bilbao A; Rodríguez de Fonseca F
Pain; 2007 Dec; 133(1-3):99-110. PubMed ID: 17449181
[TBL] [Abstract][Full Text] [Related]
19. [The endocannabinoid system and food intake control].
Rodríguez de Fonseca F
Rev Med Univ Navarra; 2004; 48(2):18-23. PubMed ID: 15382609
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism.
Sun Y; Alexander SP; Garle MJ; Gibson CL; Hewitt K; Murphy SP; Kendall DA; Bennett AJ
Br J Pharmacol; 2007 Nov; 152(5):734-43. PubMed ID: 17906680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]